NCT05962606 2026-03-18
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Aptarion Biotech AG
Phase 2 Completed
Aptarion Biotech AG
Weill Medical College of Cornell University
Hospices Civils de Lyon
Brigham and Women's Hospital
RenJi Hospital
University of Sydney